Adding Retifanlimab To First-Line Chemotherapy for Patients with Advanced Squamous Cell Anal Cancer By Ogkologos - July 15, 2025 679 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the POD1UM-303/InterAACT-2 study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR New Cancer Diagnoses Jump at Age 65, Suggesting People Put Off... March 31, 2021 Immunotherapy Drug Cemiplimab Approved for Advanced Squamous Cell Skin Cancer October 19, 2018 Community Comes Together To Give Terminally Ill Father One Last Christmas... October 18, 2021 Quitting Smoking Improves Survival in People with Lung Cancer September 14, 2021 Load more HOT NEWS FDA Grants Accelerated Approval to Adagrasib with Cetuximab for KRAS G12C-mutated... The Risk of irAEs After Immune Checkpoint Inhibitor Therapy May Not... Intensive Program Helps People Being Screened for Lung Cancer Quit Smoking Virtual Reality Could Reduce Stress for Chemo Patients, Improving Cancer Outcomes
